Form 4 for HUMA Humacyte, Inc.
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-26 · accession 0001104659-21-110538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-27 | 2021-08-26 | HUMA | Ayabudge LLC | 10% | A - Grant | — | +18.93M | 18.93M | New | — | |
| 2021-08-27 | 2021-08-26 | HUMA | Ayabudge LLC | 10% | P - Purchase | $10.00 | +1.52M | 20.45M | +8% | +$15.22M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-26 | A | A | 18,930,004 | — | 18,930,004 | D | — | — | (F1) On August 26, 2021, Alpha Health care Acquisition Corp. ("AHAC") consummated a business combination (the "Business Combination") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation ("Hunter Merger Sub") and Humacyte, Inc., a Delaware corporation ("Legacy Humacyte"), AHAC changed its name to "Humacyte, Inc." and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each share of Legacy Humacyte stock was exchanged for 0.2626 shares of common stock of Humacyte, Inc. |
| 2 | Common | Common Stock | 2021-08-26 | P | A | 1,522,500 | $10.00 | 20,452,504 | D | — | — |